Noninvasive Imaging Heisenberg Research Group – Heisenberg Radiology Research group of Marc Dewey
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer | NEJM
Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis | NEJM
Fibrosi polmonare idiopatica: su NEJM studio su una nuova terapia, coordinato da Luca Richeldi - Policlinico Universitario A. Gemelli IRCCS
Diapositiva 1
A che punto siamo con gli studi clinici randomizzati controllati (RCT)? - Informazioni sui farmaci
Nejm Article | PDF | Wechsler Adult Intelligence Scale | Docosahexaenoic Acid
Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis | NEJM
Daniel Meyerkort on LinkedIn: #exercise #jointreplacement #tkr #diet #prehab
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer | NEJM
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity | NEJM
Asco 2019 – Polo reveals an overall survival hole | Evaluate
Asco 2019 – Polo reveals an overall survival hole | Evaluate
Neoadjuvant Chemotherapy for Resectable Colorectal Cancer Liver Metastases: Indications and Results | SpringerLink
PROpel Trial Efficacy – LYNPARZA® (olaparib) for BRCAm mCRPC
Hypothermic Machine Perfusion in Liver Transplantation — A Randomized Trial | NEJM
Genes | Free Full-Text | Personalized Systemic Therapies in Hereditary Cancer Syndromes
PDF) Olaparib Maintenance Therapy in Patients With Platinum-Sensitive Relapsed Serous Ovarian Cancer
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer | NEJM
Cost-Effectiveness of Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer in: Journal of the National Comprehensive Cancer Network Volume 18 Issue 11 (2020)
Servizio Bibliotecario d'Ateneo - Biblioteca Polo San Paolo
A Randomized Trial of Intravenous Alteplase before Endovascular Treatment for Stroke | NEJM
Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral Anticoagulants: A Systematic Review and Meta-analysis - ScienceDirect
Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer | Journal of Clinical Oncology
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine | NEJM
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM
10 1056@NEJMoa2028220 PDF | PDF | Myocardial Infarction | High Density Lipoprotein
A che punto siamo con gli studi clinici randomizzati controllati (RCT)? - Area Farmacisti - Farmacie Comunali Riunite
